146 related articles for article (PubMed ID: 37144621)
21. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs.
Rabbiosi S; Peroni E; Tronconi GM; Chiumello G; Losa M; Weber G
Thyroid; 2012 Oct; 22(10):1076-9. PubMed ID: 22947349
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumours: TSH-secreting adenomas.
Beck-Peccoz P; Persani L; Mannavola D; Campi I
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):597-606. PubMed ID: 19945025
[TBL] [Abstract][Full Text] [Related]
23. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
Karavitaki N; Botusan I; Radian S; Coculescu M; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408
[TBL] [Abstract][Full Text] [Related]
24. Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
Shimatsu A; Nakamura A; Takahashi Y; Fujio S; Satoh F; Tahara S; Nishioka H; Takano K; Yamashita M; Arima H; Tominaga A; Tateishi S; Matsushita Y
Endocr J; 2021 Jul; 68(7):791-805. PubMed ID: 33692246
[TBL] [Abstract][Full Text] [Related]
25. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
26. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
[TBL] [Abstract][Full Text] [Related]
27. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
De Herdt C; Philipse E; De Block C
Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
[TBL] [Abstract][Full Text] [Related]
28. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
29. Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy.
Yoshihara A; Isozaki O; Hizuka N; Nozoe Y; Harada C; Ono M; Kawamata T; Kubo O; Hori T; Takano K
Endocr J; 2007 Feb; 54(1):133-8. PubMed ID: 17159301
[TBL] [Abstract][Full Text] [Related]
30. Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995).
Warnet A; Lajeunie E; Gelbert F; Duet M; Chanson P; Cophignon J; Harris AG
Acta Endocrinol (Copenh); 1991 Apr; 124(4):487-91. PubMed ID: 2031445
[TBL] [Abstract][Full Text] [Related]
31. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
Gruszka A; Zielinski GM; Kunert-Radek J
J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.
Broson-Chazot F; Houzard C; Ajzenberg C; Nocaudie M; Duet M; Mundler O; Marchandise X; Epelbaum J; Gomez De Alzaga M; Schäfer J; Meyerhof W; Sassolas G; Warnet A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):589-98. PubMed ID: 9425399
[TBL] [Abstract][Full Text] [Related]
33. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
34. Medical management of thyrotropin-secreting pituitary adenomas.
Beck-Peccoz P; Persani L
Pituitary; 2002; 5(2):83-8. PubMed ID: 12675505
[TBL] [Abstract][Full Text] [Related]
35. 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Beck-Peccoz P; Lania A; Beckers A; Chatterjee K; Wemeau JL
Eur Thyroid J; 2013 Jun; 2(2):76-82. PubMed ID: 24783044
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas.
Colao A; Filippella M; Di Somma C; Manzi S; Rota F; Pivonello R; Gaccione M; De Rosa M; Lombardi G
Endocrine; 2003 Apr; 20(3):279-83. PubMed ID: 12721508
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
38. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide].
Mayinger B; Axelos D; Pavel M; Hahn EG; Hensen J
Dtsch Med Wochenschr; 1999 Jan; 124(4):73-8. PubMed ID: 10071603
[TBL] [Abstract][Full Text] [Related]
39. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
Lee EJ; Kim KR; Lim SK; Lee HC; Kim DI; Kim SH; Huh KB
Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
[TBL] [Abstract][Full Text] [Related]
40. Surgical treatment and outcome of TSH-producing pituitary adenomas.
Rotermund R; Riedel N; Burkhardt T; Matschke J; Schmidt NO; Aberle J; Flitsch J
Acta Neurochir (Wien); 2017 Jul; 159(7):1219-1226. PubMed ID: 28204898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
